ADMA Biologics Inc (NASDAQ:ADMA)

Delayed Data
As of Dec 01
 -0.095 / -2.86%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 5.00, with a high estimate of 6.00 and a low estimate of 4.00. The median estimate represents a +54.80% increase from the last price of 3.23.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 9.38%
Growthannually 35.29%


Growthquarterly -1.07%
Growthannually 80.07%
Key to the earnings and sales forecast charts.